Immunomedics Inc (IMMU) SEC Filing 8-K Material Event for the period ending Tuesday, March 5, 2019

Immunomedics Inc

CIK: 722830 Ticker: IMMU

View differences made from one to another to evaluate Immunomedics Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Immunomedics Inc.


Assess how Immunomedics Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Immunomedics Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Immunomedics Inc provided additional information to their SEC Filing as exhibits

Ticker: IMMU
CIK: 722830
Form Type: 8-K Corporate News
Accession Number: 0001104659-19-013499
Submitted to the SEC: Fri Mar 08 2019 6:04:51 AM EST
Accepted by the SEC: Fri Mar 08 2019
Period: Tuesday, March 5, 2019
Industry: In Vitro And In Vivo Diagnostic Substances
  1. Event for Officers
  2. Financial Exhibit
  3. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: